Casdin Capital’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-27,407
| Closed | -$2.67M | – | 33 |
|
|
2017
Q4 | $2.67M | Buy |
27,407
+1,785
| +7% | +$174K | 0.65% | 23 |
|
|
2017
Q3 | $3.77M | Buy |
25,622
+7,408
| +41% | +$1.09M | 1.06% | 22 |
|
|
2017
Q2 | $2.93M | Hold |
18,214
| – | – | 1.08% | 23 |
|
|
2017
Q1 | $2.9M | Hold |
18,214
| – | – | 1.71% | 22 |
|
|
2016
Q4 | $2.22M | Buy |
18,214
+13,214
| +264% | +$1.61M | 1.83% | 20 |
|
|
2016
Q3 | $694K | Hold |
5,000
| – | – | 0.56% | 26 |
|
|
2016
Q2 | $908K | Buy |
+5,000
| New | +$908K | 0.9% | 23 |
|